Brief: Aker Biomarine Q2 Adjusted EBITDA Of $29.0 Million
July 12 (Reuters) - Aker Biomarine ASA AKBM.OL :
* Q2 REVENUES OF USD 94.0 MILLION (UP 6% YOY)
* Q2 ADJUSTED EBITDA OF USD 29.0 MILLION (UP 35% YOY)
* FEED INGREDIENTS BUSINESS WILL FROM Q2 2024 BE A
DISCONTINUED
SEGMENT AS IT IS CLASSIFIED AS HELD FOR SALE
Source text for Eikon: ID:nObiLw1J8a
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million